Phase III, randomized, double-blind, placebo-controlled, parallel-group, study of AB103 as compared to placebo in patients with necrotizing soft tissue infections (NSTI)###########
Sponsoring Agencies:
ATOX BIO LTD, BIOMEDICAL ADVANCED RES & DEVLPMT AUTHOR